Review



human soft tissue sarcoma ht1080 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 98
      Buy from Supplier

    Structured Review

    ATCC human soft tissue sarcoma ht1080 cells
    Human Soft Tissue Sarcoma Ht1080 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 4036 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+soft+tissue+sarcoma+ht1080+cells/HT-1080/pm41750312-66-0-7
    Average 98 stars, based on 4036 article reviews
    human soft tissue sarcoma ht1080 cells - by Bioz Stars, 2026-09
    98/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Tyrosine-Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression.
    Article Snippet: .. Human soft tissue sarcoma HT1080 cells (SC; ATCC® CCL-121TM) were cultured in fetal bovine serum (FBS), depleted Eagle’s minimum essential medium (EMEM; ATCC) supplemented with 10 ng/mL basic fibroblast growth factor (bFGF; Peprotech, Cranbury, NJ, USA), 10 ng/mL epidermal growth factor (EGF; Peprotech), and 10 μL/mL N-2 supplement (Gibco). ..

    Article Title: Tyrosine–Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression
    Article Snippet: .. Human soft tissue sarcoma HT1080 cells (SC; ATCC ® CCL-121TM) were cultured in fetal bovine serum (FBS), depleted Eagle’s minimum essential medium (EMEM; ATCC) supplemented with 10 ng/mL basic fibroblast growth factor (bFGF; Peprotech, Cranbury, NJ, USA), 10 ng/mL epidermal growth factor (EGF; Peprotech), and 10 μL/mL N-2 supplement (Gibco). ..

    Article Title: X-ray radio-enhancement by Ti 3 C 2 T x MXenes in soft tissue sarcoma
    Article Snippet: In addition, TiO 2 P90 was analysed on a Renishaw “inVia” with the “Wire” software (Renishaw plc, Gloustershire, Great-Britain). .. Human soft tissue sarcoma HT1080 cells (ATCC®CCL121TM) were cultured in minimum essential medium Eagle (MEM, Sigma-Aldrich or Gibco) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich), 1% l -glutamine (Sigma-Aldrich), 1% non-essential amino acids (NEAA, Sigma-Aldrich), 1% penicillin–streptomycin (PS, Sigma-Aldrich) and 1 mM sodium-pyruvate at 37 °C under a humidified atmosphere containing 5% CO 2 . .. Subculturing was conducted at 70–80% confluency by treatment with 0.5% Trypsin-EDTA (Sigma-Aldrich).



    Similar Products

    human soft tissue sarcoma ht1080 cells  (ATCC)
    98
    ATCC human soft tissue sarcoma ht1080 cells
    Human Soft Tissue Sarcoma Ht1080 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+soft+tissue+sarcoma+ht1080+cells/HT-1080/pm41750312-66-0-7
    Average 98 stars, based on 1 article reviews
    human soft tissue sarcoma ht1080 cells - by Bioz Stars, 2026-09
    98/100 stars
    		  Buy from Supplier
    culture conditions human soft tissue sarcoma ht1080 cells  (ATCC)
    98
    ATCC culture conditions human soft tissue sarcoma ht1080 cells
    Fig. 4 Surviving fractions of human soft tissue sarcoma cells irradiated at different X-ray doses, relative to untreated, non-irradiated control, treated with (a) fresh Ti3C2Tx MXenes, (b) aged Ti3C2Tx MXenes and (c) TiO2 (P90). (d) Dose-modifying ratio (DMR) at 50% cell survival for afore- mentioned particle types and different concentrations in <t>HT1080</t> (* indi- cates p < 0.05). (e–g) Surviving fractions of normal human dermal fibro- blasts irradiated at different X-ray doses, relative to untreated, non-irra- diated control, treated with (e) fresh Ti3C2Tx MXenes, (f) aged Ti3C2Tx MXenes and (g) TiO2 (P90).
    Culture Conditions Human Soft Tissue Sarcoma Ht1080 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+soft+tissue+sarcoma+ht1080+cells/HT-1080/pm37878039-174-52-60
    Average 98 stars, based on 1 article reviews
    culture conditions human soft tissue sarcoma ht1080 cells - by Bioz Stars, 2026-09
    98/100 stars
    		  Buy from Supplier
    human soft tissue sarcoma cell lines ht1080  (ATCC)
    98
    ATCC human soft tissue sarcoma cell lines ht1080
    Doxorubicin and TRAIL combination decreases fibrosarcoma <t>(HT1080)</t> growth in vivo. A) Tumor growth curves per treatment group (left; n=10mice/group, p<0.01) and tumor pictures (right upper panel). Box plots (right lower panel) depict average tumor weights at termination of the study (p<0.001); B) Ki-67 immunoflorescence (blue =nuclei, green = Ki-67) and TUNEL staining (blue = nuclei, green =TUNEL) of HT1080 xenograft specimens (selected for presence of viable tumor shown in H+E); C) DR4 (green) and DR5 (red) immunoflorescent staining of HT1080 xenografts (nuclei are depicted in blue).
    Human Soft Tissue Sarcoma Cell Lines Ht1080, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+soft+tissue+sarcoma+ht1080+cells/HT-1080/pmc02967255-135-0-18
    Average 98 stars, based on 1 article reviews
    human soft tissue sarcoma cell lines ht1080 - by Bioz Stars, 2026-09
    98/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 4 Surviving fractions of human soft tissue sarcoma cells irradiated at different X-ray doses, relative to untreated, non-irradiated control, treated with (a) fresh Ti3C2Tx MXenes, (b) aged Ti3C2Tx MXenes and (c) TiO2 (P90). (d) Dose-modifying ratio (DMR) at 50% cell survival for afore- mentioned particle types and different concentrations in HT1080 (* indi- cates p < 0.05). (e–g) Surviving fractions of normal human dermal fibro- blasts irradiated at different X-ray doses, relative to untreated, non-irra- diated control, treated with (e) fresh Ti3C2Tx MXenes, (f) aged Ti3C2Tx MXenes and (g) TiO2 (P90).

    Journal: Biomaterials science

    Article Title: X-ray radio-enhancement by Ti 3 C 2 T x MXenes in soft tissue sarcoma.

    doi: 10.1039/d3bm00607g

    Figure Lengend Snippet: Fig. 4 Surviving fractions of human soft tissue sarcoma cells irradiated at different X-ray doses, relative to untreated, non-irradiated control, treated with (a) fresh Ti3C2Tx MXenes, (b) aged Ti3C2Tx MXenes and (c) TiO2 (P90). (d) Dose-modifying ratio (DMR) at 50% cell survival for afore- mentioned particle types and different concentrations in HT1080 (* indi- cates p < 0.05). (e–g) Surviving fractions of normal human dermal fibro- blasts irradiated at different X-ray doses, relative to untreated, non-irra- diated control, treated with (e) fresh Ti3C2Tx MXenes, (f) aged Ti3C2Tx MXenes and (g) TiO2 (P90).

    Article Snippet: T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al 3 .0 U np or te d L ic en ce Cell lines and culture conditions Human soft tissue sarcoma HT1080 cells (ATCC®CCL121TM) were cultured in minimum essential medium Eagle (MEM, Sigma-Aldrich or Gibco) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich), 1% L-glutamine (Sigma-Aldrich), 1% non-essential amino acids (NEAA, Sigma-Aldrich), 1% penicillin–streptomycin (PS, Sigma-Aldrich) and 1 mM sodium-pyruvate at 37 °C under a humidified atmosphere containing 5% CO2.

    Techniques: Irradiation, Control

    Doxorubicin and TRAIL combination decreases fibrosarcoma (HT1080) growth in vivo. A) Tumor growth curves per treatment group (left; n=10mice/group, p<0.01) and tumor pictures (right upper panel). Box plots (right lower panel) depict average tumor weights at termination of the study (p<0.001); B) Ki-67 immunoflorescence (blue =nuclei, green = Ki-67) and TUNEL staining (blue = nuclei, green =TUNEL) of HT1080 xenograft specimens (selected for presence of viable tumor shown in H+E); C) DR4 (green) and DR5 (red) immunoflorescent staining of HT1080 xenografts (nuclei are depicted in blue).

    Journal:

    Article Title: TRAIL and doxorubicin combination induces pro-apoptotic and anti-angiogenic effects in soft tissue sarcoma in vivo

    doi: 10.1158/1078-0432.CCR-09-2443

    Figure Lengend Snippet: Doxorubicin and TRAIL combination decreases fibrosarcoma (HT1080) growth in vivo. A) Tumor growth curves per treatment group (left; n=10mice/group, p<0.01) and tumor pictures (right upper panel). Box plots (right lower panel) depict average tumor weights at termination of the study (p<0.001); B) Ki-67 immunoflorescence (blue =nuclei, green = Ki-67) and TUNEL staining (blue = nuclei, green =TUNEL) of HT1080 xenograft specimens (selected for presence of viable tumor shown in H+E); C) DR4 (green) and DR5 (red) immunoflorescent staining of HT1080 xenografts (nuclei are depicted in blue).

    Article Snippet: Human soft tissue sarcoma cell lines HT1080 (fibrosarcoma; wild type p53) and SKLMS1 (leiomyosarcoma; mutated p53)were obtained from ATCC.

    Techniques: In Vivo, TUNEL Assay, Staining

    Doxorubicin and TRAIL combination inhibits fibrosarcoma (HT1080) lung metastases growth and enhances survival. A) BLI images of one representative mice of each treatment arm are shown demonstrating the markedly decreased luciferase readout in combination treated mice compared to control or either compound alone. Pictures and H+E staining demonstrate the reduction in lung metastatic deposits (arrows) in combination treated mice; B) Box plots demonstrating the significant decrease in lung weight of combination treated mice (*p<0.005); C) Kaplan Meier survival curves demonstrating a statistically significant prolongation in overall survival of mice treated with doxorubicin/TRAIL combination (p=0.001)

    Journal:

    Article Title: TRAIL and doxorubicin combination induces pro-apoptotic and anti-angiogenic effects in soft tissue sarcoma in vivo

    doi: 10.1158/1078-0432.CCR-09-2443

    Figure Lengend Snippet: Doxorubicin and TRAIL combination inhibits fibrosarcoma (HT1080) lung metastases growth and enhances survival. A) BLI images of one representative mice of each treatment arm are shown demonstrating the markedly decreased luciferase readout in combination treated mice compared to control or either compound alone. Pictures and H+E staining demonstrate the reduction in lung metastatic deposits (arrows) in combination treated mice; B) Box plots demonstrating the significant decrease in lung weight of combination treated mice (*p<0.005); C) Kaplan Meier survival curves demonstrating a statistically significant prolongation in overall survival of mice treated with doxorubicin/TRAIL combination (p=0.001)

    Article Snippet: Human soft tissue sarcoma cell lines HT1080 (fibrosarcoma; wild type p53) and SKLMS1 (leiomyosarcoma; mutated p53)were obtained from ATCC.

    Techniques: Luciferase, Control, Staining